RAPPRapport Therapeutics, Inc.
$25.87+4.0% 1Y
$25.87
$24.3752 weeks$52.44
Is the business good?
How good a business is RAPP?
- Share count, year on year
- +34%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$97M
- Net income, trailing twelve months
- −$137M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Biotechnology
The closest names by size in the same industry